100 related articles for article (PubMed ID: 21539449)
1. Knockdown of osteopontin chemosensitizes MDA-MB-231 cells to cyclophosphamide by enhancing apoptosis through activating p38 MAPK pathway.
Pang H; Cai L; Yang Y; Chen X; Sui G; Zhao C
Cancer Biother Radiopharm; 2011 Apr; 26(2):165-73. PubMed ID: 21539449
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of osteopontin expression by RNA interference affects cell proliferation and chemotherapy sensitivity of breast cancer MDA-MB-231 cells.
Yang L; Wei L; Zhao W; Wang X; Zheng G; Zheng M; Song X; Zuo W
Mol Med Rep; 2012 Feb; 5(2):373-6. PubMed ID: 22143930
[TBL] [Abstract][Full Text] [Related]
3. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
5. Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells.
Hahnel A; Wichmann H; Kappler M; Kotzsch M; Vordermark D; Taubert H; Bache M
Radiat Oncol; 2010 Sep; 5():82. PubMed ID: 20849637
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway.
Huang RH; Quan YJ; Chen JH; Wang TF; Xu M; Ye M; Yuan H; Zhang CJ; Liu XJ; Min ZJ
Cell Physiol Biochem; 2017; 41(5):1851-1864. PubMed ID: 28376477
[TBL] [Abstract][Full Text] [Related]
7. Requirement of p38 MAPK for a cell-death pathway triggered by vorinostat in MDA-MB-231 human breast cancer cells.
Uehara N; Kanematsu S; Miki H; Yoshizawa K; Tsubura A
Cancer Lett; 2012 Feb; 315(2):112-21. PubMed ID: 22093617
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic potential of cardiotoxin III involves inactivation of PI3K/Akt and p38 MAPK signaling pathways in human breast cancer MDA-MB-231 cells.
Lin KL; Chien CM; Hsieh CY; Tsai PC; Chang LS; Lin SR
Life Sci; 2012 Jan; 90(1-2):54-65. PubMed ID: 22079475
[TBL] [Abstract][Full Text] [Related]
9. MAPK pathway and SIRT1 are involved in the down-regulation of secreted osteopontin expression by genistein in metastatic cancer cells.
Khongsti K; Das KB; Das B
Life Sci; 2021 Jan; 265():118787. PubMed ID: 33249095
[TBL] [Abstract][Full Text] [Related]
10. Conditional Knockdown of Osteopontin Inhibits Breast Cancer Skeletal Metastasis.
Kovacheva M; Zepp M; Schraad M; Berger S; Berger MR
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590218
[TBL] [Abstract][Full Text] [Related]
11. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl‑2 pathway.
Qian C; Li P; Yan W; Shi L; Zhang J; Wang Y; Liu H; You Y
Mol Med Rep; 2015 Mar; 11(3):1951-5. PubMed ID: 25405848
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
Shi YY; Small GW; Orlowski RZ
Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.
Shevde LA; Samant RS; Paik JC; Metge BJ; Chambers AF; Casey G; Frost AR; Welch DR
Clin Exp Metastasis; 2006; 23(2):123-33. PubMed ID: 16830223
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.
Tajima K; Ohashi R; Sekido Y; Hida T; Nara T; Hashimoto M; Iwakami S; Minakata K; Yae T; Takahashi F; Saya H; Takahashi K
Oncogene; 2010 Apr; 29(13):1941-51. PubMed ID: 20101228
[TBL] [Abstract][Full Text] [Related]
16. Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells.
Li X; Zhao SJ; Shi HL; Qiu SP; Xie JQ; Wu H; Zhang BB; Wang ZT; Yuan JY; Wu XJ
Oncol Rep; 2014 Dec; 32(6):2777-88. PubMed ID: 25335112
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin-mediated activation of Akt2 protects human ovarian and breast cancer cells from docetaxel-induced apoptosis via inhibition of the p38 pathway.
Xing H; Cao Y; Weng D; Tao W; Song X; Wang W; Meng L; Xu G; Zhou J; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):213-23. PubMed ID: 18158623
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
Small GW; Shi YY; Higgins LS; Orlowski RZ
Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway.
Hsieh MJ; Chen KS; Chiou HL; Hsieh YS
Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]